Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II.
Saved in:
| Title: | Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II. |
|---|---|
| Authors: | Ellison M; University of Pittsburgh Medical Center, Histocompatibility Laboratory, Pittsburgh, PA, United States., Mangiola M; Transplant Institute, NYU Langone Health, New York University, New York, NY, United States., Marrari M; Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Bentlejewski C; Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Sadowski J; University of Pittsburgh Medical Center, Histocompatibility Laboratory, Pittsburgh, PA, United States., Zern D; University of Pittsburgh Medical Center, Histocompatibility Laboratory, Pittsburgh, PA, United States., Kramer CSM; Department of Immunology, Leiden University Medical Center (LUMC), Leiden, Netherlands., Heidt S; Department of Immunology, Leiden University Medical Center (LUMC), Leiden, Netherlands., Niemann M; Research and Development, PIRCHE AG, Berlin, Germany., Xu Q; Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Dipchand AI; Labatt Heart Centre, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada., Mahle WT; Children's Healthcare of Atlanta, Emory University, Atlanta, GA, United States., Rossano JW; Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, United States., Canter CE; Division of Cardiology, Department of Pediatrics, School of Medicine, University of Washington, Seattle, WA, United States., Singh TP; Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States., Zuckerman WA; Columbia University, Irving Medical Center, New York, NY, United States., Hsu DT; Division of Pediatric Cardiology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York, NY, United States., Feingold B; Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, PA, United States., Webber SA; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, United States., Zeevi A; Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2023 Mar 14; Vol. 14, pp. 1110292. Date of Electronic Publication: 2023 Mar 14 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
